Orthopedics Report Cover TrendFeedr

Orthopedics Report

: Analysis on the Market, Trends, and Technologies
18.5K
TOTAL COMPANIES
Widespread
Topic Size
Incremental
ANNUAL GROWTH
Plummeting
trending indicator
37.5B
TOTAL FUNDING
Maturing
Topic Maturity
Balanced
TREND HYPE
928.0K
Monthly Search Volume
Updated: December 5, 2025

The orthopedics sector is facing a high-growth, capital-intensive phase driven by demographic demand and rapid technology adoption: the market ecosystem now includes 19,740 active companies and has attracted $37.43B in total funding to date, concentrating revenue and investment in platform providers while creating entry points for specialized ingredient suppliers. Market forecasts vary by scope but consistently show expansion: U.S. orthopedics is estimated at $59.2B (2024) with a path to $86.4B by 2030 Orthopedic Market Insights – Spring 2025 – Hyde Park Capital, and global device projections place the market near $52.8B (2024) with projected growth to $86.0B by 2032 Global Orthopedic Devices Market – DataBridge Market Research. Collectively, data and patent activity point to a shift from single-product mechanical plays to software-enabled, patient-specific and data-driven solutions that capture post-acute outcomes and recurring revenue Technology Landscape, Trends and Opportunities in the Global Orthopedic Device Market.

The last time we updated this report was 85 days ago. If there’s something missing or off, your tips are welcome!

Topic Dominance Index of Orthopedics

The Dominance Index for Orthopedics merges timelines of published articles, newly founded companies, and global search data to provide a comprehensive perspective into the topic.

Dominance Index growth in the last 5 years: -26.64%
Growth per month: -0.52%

Key Activities and Applications

  • Joint replacement (hip, knee, shoulder) — adoption of modular and cementless implants remains the principal revenue engine; implant sales account for the majority of device value and continue to drive surgery volumes Orthopedic Market 2025: In-Depth Analysis.
  • Minimally invasive and outpatient workflows (ASCs) — migration of elective orthopedics into ambulatory surgical centers increases throughput and lowers per-case cost, pressuring device makers to support faster turnover and compact instrumentation Orthopedic Products Manufacturing in the US.
  • Regenerative interventions and orthobiologics — injectable biologics (PRP, allografts, bone graft substitutes) are being deployed as either adjuncts to surgery or alternatives for early disease stages, creating cross-sell opportunities for device firms Orthobiologics Market Report.
  • Orthotics and custom O&P — CAD/CAM and onsite 3D printing shorten lead times for custom braces and insoles, supporting faster return to function in trauma and sports medicine pathways Orthotics Market Outlook 2025.
  • Remote rehabilitation and RPM — sensor-enabled motion monitoring platforms capture compliance and functional recovery metrics that payers and systems can monetize under value-based contracts.

Technologies and Methodologies

  • Robotic-assisted surgical systems and navigation — from joint reconstruction to spine, these systems supply intraoperative metrics that can be fed into predictive models for implant selection and placement.
  • Additive manufacturing (MLS / EBM / polymer printing) — patient-specific implants, porous structures for osseointegration, and rapid orthotic fabrication lower time-to-fit and improve mechanical matching 3D Orthopedics/Prosthetics Market Overview 2025.
  • Sensorized implants and wearables — embedded load and motion sensors enable objective rehabilitation metrics; combined with cloud analytics these products create recurring revenue via monitoring services.
  • AI-driven preoperative planning and digital twins — imaging + biomechanical modeling generates patient-specific surgical plans and implant geometry, reducing intraoperative variability and potential revision risk.
  • Orthobiologics & regenerative scaffolds — viscosupplementation, allografts, BMPs and synthetic bone substitutes advance as adjuncts to preserve joints or accelerate fusion, with projected high single-digit to low-double-digit CAGR in specialist segments.

Orthopedics Funding

A total of 1.8K Orthopedics companies have received funding.
Overall, Orthopedics companies have raised $37.5B.
Companies within the Orthopedics domain have secured capital from 4.2K funding rounds.
The chart shows the funding trendline of Orthopedics companies over the last 5 years

Funding growth in the last 5 years: 184.96%
Growth per month: 1.79%

Orthopedics Companies

  • OBTGOBTG operates as a clinical network and treatment provider focused on minimally invasive regenerative orthopedics (PRP and stem-cell derived procedures), positioning itself as a high-volume non-surgical pathway that can reduce immediate surgical demand and serve as an acquisition target for integrated platforms seeking orthobiologic capability. OBTG's model emphasizes standardized biologic protocols and international reach, which can accelerate payer acceptance when supported by outcomes data.
  • OrthoKinetic Track IncOrthoKinetic Track Inc provides an AI-enabled, IoT platform that monitors shoulder motion and muscle activity remotely; the product targets the high-variability, high-cost rehab phase and has raised $1.50M in venture funding to commercialize its telemetry and analytics stack. By delivering objective functional endpoints, the company can influence episode-based pricing and post-acute contracting.
  • O & P IN MOTION INCO & P IN MOTION INC specializes in pediatric and scoliosis bracing using CAD/CAM workflows for customized orthoses; its low overhead and targeted clinical focus make it attractive to regional clinics seeking faster fabrication and higher patient satisfaction. The company's practice-level integration reduces lead time compared with legacy casting methods.
  • Orthopedics-CloudOrthopedics-Cloud, powered by WRS Health, supplies a cloud-native EHR and practice management stack tailored to orthopedic surgical workflows, including preoperative clearance and MIPS/MACRA support; this infrastructure can be a multiplier for groups scaling multi-site ASCs and capturing longitudinal outcome data. Its certification and specialty templates reduce operational friction for medium-sized practices transitioning to integrated care models.
  • OrthoLA - Orthopaedic sports medicine, joint & hand specialistsOrthoLA is a multi-site regional practice that bundles specialty surgeons with onsite therapy and imaging to capture referral and post-operative volume; it exemplifies the platform aggregator that investors target for consolidation and ASC expansion. The practice model highlights how clinical scale creates negotiating leverage with device suppliers and payers alike.

Delve into the corporate landscape of Orthopedics with TrendFeedr’s Companies tool

companies image

18.5K Orthopedics Companies

Discover Orthopedics Companies, their Funding, Manpower, Revenues, Stages, and much more

View all Companies

Orthopedics Investors

TrendFeedr’s Investors tool provides insights into 2.9K Orthopedics investors for you to keep ahead of the curve. This resource is critical for analyzing investment activities, funding trends, and market potential within the Orthopedics industry.

investors image

2.9K Orthopedics Investors

Discover Orthopedics Investors, Funding Rounds, Invested Amounts, and Funding Growth

View all Investors

Orthopedics News

TrendFeedr’s News feature offers you access to 9.1K articles on Orthopedics. Stay informed about the latest trends, technologies, and market shifts to enhance your strategic planning and decision-making.

articles image

9.1K Orthopedics News Articles

Discover Latest Orthopedics Articles, News Magnitude, Publication Propagation, Yearly Growth, and Strongest Publications

View all Articles

Executive Summary

The data indicate a sector where scale and data capture determine near-term winners: platform providers that integrate diagnostics, ASCs, and rehabilitation will secure the lion's share of revenue and negotiating power, while narrowly focused innovators (regenerative protocols, patient-specific implants, RPM analytics) can monetize high margins by supplying essential "ingredients" for those platforms. Strategic priorities for market participants are clear: secure post-acute data flows, reduce supply-chain exposure through localized manufacturing, and align product development to payer-measured functional outcomes. Firms that align clinical endpoints with commercial contracting will convert technological promise into sustainable revenue.

Are you an insider in the trends or tech industry? We’d love for you to contribute to our content.

StartUs Insights logo

Discover our Free Healthcare Trends Report

DOWNLOAD
Discover emerging Healthcare Trends!
We'll deliver our free report straight to your inbox!



    Protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Spot Emerging Trends Before Others

    Get access to the full database of 20,000 trends



      Protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.




        This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

        Let's talk!



          Protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.